In the field of personalized medicine, genetically tailored stem cell treatments are becoming feasible, raising the prospect of treating complex diseases such as AD with specialized gene editing to correct mutations in the APP, PSEN1 or PSEN2 genes (Wang S. W. et al., 2022). The gene discussed is APP; the disease is Alzheimer disease.